Literature DB >> 6224017

Autologous mixed lymphocyte reaction in man. VI. Deficiency of autologous mixed lymphocyte reaction in type I (insulin-dependent) diabetes mellitus.

S Gupta, S Fikrig, E Orti.   

Abstract

Autologous mixed lymphocyte reaction (AMLR) was examined in the peripheral blood from 20 patients with type I (insulin-dependent) diabetes mellitus. Six of 20 patients demonstrated deficient AMLR when compared to the range for simultaneously studied age and sex matched healthy controls. The kinetics of AMLR with regard to duration of the peak proliferative response was similar to controls, the peak response being on day 6. In allogeneic MLR. T cells from patients responded normally. However, non-T cells from patients were poor stimulators against responder T cells from healthy controls. This study demonstrates a deficiency of AMLR in a subset of patients with type I diabetes that further supports an abnormal immune regulation and might be an important mechanism in the pathogenesis and autoimmune manifestations of type I diabetes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224017

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  5 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.

Authors:  L Räsänen; H Hyöty; M Lehto; O P Kallioniemi; J Antonen; T Huupponen; J Karjalainen; P Leinikki
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 3.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

4.  Autologous mixed lymphocyte reaction in man: XV. Cellular and molecular basis of deficient autologous mixed lymphocyte response in insulin-dependent diabetes mellitus.

Authors:  K G Chandy; A M Charles; A Kershnar; B Buckingham; N Waldeck; S Gupta
Journal:  J Clin Immunol       Date:  1984-11       Impact factor: 8.317

Review 5.  Vaccine therapies for the prevention of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.